Biotech and Pharmaceuticals
Omicron XBB.1.5 does not have mutations known to make people sicker, WHO says
A man is getting a Covid-19 test at a Covid-19 mobile testing site as people lined up at the Times Square in New York City, on Dec 6, 2021. Tayfun Coskun | Anadolu Agency | Getty Images The omicron XBB.1.5 subvariant does not have any mutations known to make people sicker when they catch the […]
Read More
Watch stay: Nassau County GOP officers simply call on Rep. George Santos to ‘immediately resign’ around campaign lies
(The press conference is scheduled to begin at 11:30 a.m. ET. Please refresh the site if the over online video won’t get started at that time.) Top Republicans in Nassau County, New York, called on GOP Rep. George Santos to right away resign Wednesday for fabricating main details of his resume, blasting the freshman lawmaker […]
Read More
Biden administration extends Covid public health and fitness emergency as really infectious omicron XBB.1.5 spreads
Folks wearing masks stroll subsequent to coronavirus sickness (COVID-19) tests site in New York Metropolis, New York, U.S., December 12, 2022. Eduardo Munoz | Reuters The Biden administration has prolonged the Covid-19 public wellbeing emergency until finally April as a very transmissible omicron subvariant stokes concern that the U.S. may facial area a further wave […]
Read More
Sen. Bernie Sanders urges Moderna not to hike price of Covid-19 vaccines
Sen. Bernie Sanders on Tuesday urged Moderna not to quadruple the price of its Covid-19 vaccine once distribution of the shots moves to the commercial market. In a letter to Moderna CEO Stephane Bancel, Sanders called the price increase “outrageous.” The independent senator from Vermont and incoming chair of the Senate’s health committee said such […]
Read More
Pfizer CEO states there will be no generic Paxlovid for China
An on-line pharmacy lists Pfizer’s oral anti-Covid drug Paxlovid for 2,980 yuan for every box in in Suqian, Jiangsu province, China on Dec. 13, 2022. CFOTO | Future Publishing | Getty Images Pfizer is not in talks with Chinese authorities to license a generic model of its Covid-19 treatment Paxlovid for use there, but is […]
Read More
Most Alzheimer’s patients would pay up to $26,500 per year for new treatment Leqembi
Few seniors with early Alzheimer’s disease will have access to the new treatment Leqembi due to its high cost and very limited coverage by Medicare. The Food and Drug Administration on Friday granted accelerated approval to Biogen and Eisai’s monoclonal antibody after the treatment appeared to modestly slow the progression of Alzheimer’s disease in clinical […]
Read More
Bank of The us just added these biotech shares to its listing of 1st-quarter picks
BofA has extra a amount of biotechnology stocks — a sector that is warm on Wall Street suitable now – to its listing of prime picks for the very first quarter. The bank discovered the biotech stocks, as properly as some health care know-how organizations, as element of its thematic investing picks, on themes it […]
Read More
Fda approves Alzheimer’s drug that slowed cognitive decrease in medical demo
MRI picture of mind showing region of Alzheimer affected individual. Getty Illustrations or photos The Food items and Drug Administration on Friday granted accelerated approval for the Alzheimer’s drug lecanemab, formulated by Biogen and the Japanese pharmaceutical firm Eisai. The FDA’s approval will come immediately after scientific trial benefits published in November indicated that lecanemab […]
Read More
Omicron XBB.1.5 is rising in U.S. though revised CDC data shows slower increase than previously reported
The Centers for Disease Control and Prevention on Friday revised downward its estimate of how much the omicron XBB.1.5 subvariant is circulating across the U.S., though it continues to spread at a faster pace than other versions of Covid-19. XBB.1.5 made up 27.6% of sequenced Covid cases nationally for the week ending Jan. 7 compared […]
Read More
Health-care ETFs tend to rise around next week’s annual JPMorgan conference. Here’s what to know
Next week is one of the biggest of the year for health-care investors, and it has historically been a good time to own ETFs that track the industry. The 2023 JPMorgan Health Care Conference is set to kick off next Monday in San Francisco. The event features keynote speeches from the CEOs of Sage Therapeutics […]
Read More